24 May 2024
24 May 2024
Guardant’s blood cancer test can detect the presence of altered tumour cell DNA to screen for colon cancer.
Taking to the stage as part of the MedTech Forum 2024, representatives from the World Health Organization and the European Commission urged manufacturers to be wary of their carbon output.
Belong.Life asked a group of senior oncologists to review the responses provided to patients and caregivers by Dave.
The Heuron ICH solution can quickly identify emergency brain haemorrhages, with a reported sensitivity of 86%.
The device is designed to modulate the immune response by targeting and removing pro-inflammatory neutrophils and monocytes.
The SCOPEYE 3D solution includes the 3D Microvision, and the 3D AddON device.
The study will explore the potential of cortical stimulation in stroke rehabilitation to enhance brain plasticity.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
